Fundamental dimension Equity attribute | RSGPeer $239.93▼-0.82% Cap $73.47BP/E 34.0x QuantScore45/100 | CWSTPeer $97.61▲+0.74% Cap $6.12BP/E 1047.3x QuantScore41/100 | GFLLeader $45.56▲+3.22% Cap $15.90BP/E -100.3x QuantScore49/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
83/100 |
75/100 |
85/100 |
Valuation Multiples, PEG & DCF upside | 55/100 | 43/100 | 34/100 |
Health Piotroski, Altman Z, leverage & liquidity | 29/100 | 30/100 | 17/100 |
Growth Revenue / earnings growth & margins | 24/100 | 35/100 | 42/100 |
Sentiment Analyst ratings, targets & revisions | 35/100 | 22/100 | 66/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 34.0x | 1047.3x | -100.3x |
Forward P/E (next FY) | 33.0x | 72.2x | 54.9x |
EV / EBITDA (TTM) | 15.6x | 18.9x | 17.7x |
Price / Sales | 4.3x | 3.1x | 3.2x |
Price / Free Cash Flow | 21.6x | 57.9x | 114.5x |
PEG ratio | 7.93 | -21.72 | 0.25 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 5 / 9 | 6 / 9 | 5 / 9 |
Altman Z-Score | 3.12 (Safe) | 2.42 (Grey) | 1.30 (Distress) |
Total debt / equity | 1.19 | 0.91 | 1.38 |
Quick ratio | 0.6x | 1.0x | 0.8x |
Interest coverage | 5.7x | 1.4x | 0.7x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +3.5% | +18.0% | +7.8% |
Net income growth YoY | +4.7% | -41.9% | +630.5% |
Gross margin (TTM) | 39.1% | 25.4% | 20.0% |
Operating margin (FY) | 20.0% | 4.9% | 5.2% |
FCF margin (FY) | 14.5% | 4.6% | 2.6% |
5. Trailing price performancePrice change over period |
1M return | +13.0% | +16.4% | +9.0% |
3M return | +10.9% | +9.2% | +14.8% |
6M return | +14.6% | +21.7% | +12.7% |
Year to date | +13.5% | -0.3% | +6.1% |
1Y return | +7.8% | +10.3% | -0.0% |
3Y return | +67.8% | +30.1% | +55.2% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $251.32 +4.7% upside | $157.75 +61.6% upside | $14.27 -68.7% premium |
Wall Street consensus target | $234.57 -2.2% · range $219.00–$244.00 | $101.67 +4.2% · range $95.00–$106.00 | $56.50 +24.0% · range $55.00–$58.00 |
Consensus stance | 54% Buy46% Hold0% Sell | 53% Buy47% Hold0% Sell | 78% Buy17% Hold6% Sell |